These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34309530)

  • 1. Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases.
    Cozzani E; Gasparini G; Sticchi L; Russo R; Icardi G; Parodi A
    Eur J Dermatol; 2021 Jun; 31(3):415-417. PubMed ID: 34309530
    [No Abstract]   [Full Text] [Related]  

  • 2. Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
    Di Altobrando A; Patrizi A; Bardazzi F
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e295-e297. PubMed ID: 32302437
    [No Abstract]   [Full Text] [Related]  

  • 3. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report.
    Golding B; Lee Y; Golding H; Khurana S
    Ann Rheum Dis; 2021 Oct; 80(10):1359-1361. PubMed ID: 34272252
    [No Abstract]   [Full Text] [Related]  

  • 4. Azathioprine in the treatment of autoimmune blistering diseases.
    Meyer V; Beissert S
    Immunol Allergy Clin North Am; 2012 May; 32(2):295-307, vii-viii. PubMed ID: 22560142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
    Alexander JL; Selinger CP; Powell N;
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):987-988. PubMed ID: 34653395
    [No Abstract]   [Full Text] [Related]  

  • 6. [COVID-19 vaccines and cancer patients: State of the art and guidelines summary].
    Kharmoum S; El M'Rabet FZ
    Bull Cancer; 2021 May; 108(5):553-555. PubMed ID: 33902920
    [No Abstract]   [Full Text] [Related]  

  • 7. An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.
    Gresham LM; Marzario B; Dutz J; Kirchhof MG
    J Am Acad Dermatol; 2021 Jun; 84(6):1652-1666. PubMed ID: 33482251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):145-146. PubMed ID: 34550960
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
    Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].
    Barrière J; Audigier-Valette C; Borchiellini D; Hoch B; Castelnau O; Francois E; Gastaud L; Skaf R; Berdah JF; Marie W; Lescaut W; Peyrade F; Cluzeau T; Cassuto O; Carles M
    Bull Cancer; 2021 Apr; 108(4):341-342. PubMed ID: 33741139
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
    Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
    J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 and the rheumatology patient: the last 12 months and a boost in the future.
    Winthrop KL; Whitley RJ; Aletaha D
    Ann Rheum Dis; 2021 Oct; 80(10):1249-1251. PubMed ID: 34518198
    [No Abstract]   [Full Text] [Related]  

  • 13. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection.
    Xu W; Su S; Jiang S
    Clin Transl Med; 2021 Feb; 11(2):e331. PubMed ID: 33634979
    [No Abstract]   [Full Text] [Related]  

  • 14. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of autoimmune blistering diseases in pregnancy.
    McPherson T; Venning VV
    Dermatol Clin; 2011 Oct; 29(4):585-90. PubMed ID: 21925002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
    Tau N; Manuel O; Rozen-Zvi B; Shargian L; Yahav D
    Clin Microbiol Infect; 2021 Dec; 27(12):1727-1728. PubMed ID: 34391930
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted.
    Ewen S; Neumann F; Bittenbring JT; von Scheidt W; Böhm M
    Clin Res Cardiol; 2021 Aug; 110(8):1139-1141. PubMed ID: 34241675
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single dose of SARS-CoV-2 mRNA vaccine in post-COVID-19 elderly people].
    Nieto Colino S; Cid Abasolo FJ; Martínez Hernández J
    Rev Esp Geriatr Gerontol; 2021; 56(5):312-313. PubMed ID: 34172313
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines.
    Fan Y; Geng Y; Wang Y; Deng X; Li G; Zhao J; Ji L; Zhang X; Song Z; Zhang H; Sun X; Gao D; Xie W; Huang H; Hao Y; Zhang Z
    Ann Rheum Dis; 2022 Mar; 81(3):443-445. PubMed ID: 34824048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.